Clinical Trials Directory

Trials / Unknown

UnknownNCT04960293

Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids

"Comparison of Pain After Uterine Artery Embolization Using Spherical Gelfoam or Tris-acryl Gelatin Microsphere in Patients With Symptomatic Fibroids: A Prospective, Randomized Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to compare pain after uterine artery embolization using spherical gelfoam or tris-acryl gelatin microsphere in patients with symptomatic fibroids

Detailed description

Uterine artery embolization(UAE) is a minimally invasive treatment alternative to hysterectomy and myomectomy in symptomatic fibroids. However, post-procedural pain after UAE remains a major problem. The spherical gelfoam and tri-acryl gelatin microsphere are two embolic materials used for UAE. Therefore, the aim of study is to compare pain intensity and inflammation after uterine artery embolization using the two embolic agents with symptomatic fibroids.

Conditions

Interventions

TypeNameDescription
PROCEDUREuterine artery embolization using spherical gelfoamUterine artery embolization is performed using spherical gelfoam. All other processes are same.
PROCEDUREuterine artery embolization using tri-acryl gelatin microsphereUterine artery embolization is performed using tris-acryl gelatin microsphere. All other processes are same.

Timeline

Start date
2021-07-01
Primary completion
2023-05-01
Completion
2023-05-01
First posted
2021-07-13
Last updated
2021-07-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04960293. Inclusion in this directory is not an endorsement.